Literature DB >> 31571134

Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activity.

Gabriella Santangelo1, Marida Della Corte2,3, Maddalena Sparaco2, Giuseppina Miele2, Federica Garramone4, Maria Cropano4, Sabrina Esposito2, Luigi Lavorgna2, Antonio Gallo2, Gioacchino Tedeschi2,3, Simona Bonavita2,3.   

Abstract

Few studies evaluated coping strategies in people with multiple sclerosis (pwMS) in relation to annualized relapse rate (ARR) and lesion load (LL). Overall, results might have been influenced by the inclusion of depressed patients. To investigate the coping strategies and their association to disease activity, we studied relapsing-remitting pwMS accurately selected to avoid the confounding effect of depression. Sixty-seven relapsing-remitting pwMS and 67 healthy subjects (HS) underwent to Coping Orientation to Problems Experienced (I-COPE) and Coping Inventory for Stressful Situation (CISS) and Beck Depression Inventory-II. Cognitive performances, ARR, physical disability and magnetic resonance imaging T2-LL were assessed for correlation with coping and depression scores. pwMS showed lower scores than HSs on social support and turning to religion subscales of I-COPE and on emotion dimension of CISS. In pwMS, higher ARR was related to higher positive attitude and lower score on the turning to religion subscale of I-COPE. The present study revealed a less employment of emotion-based coping strategies in pwMS. A scarce use of faith for support and a frequent adoption of a positive attitude were associated with an increase of MS activity in terms of ARR.

Entities:  

Keywords:  Clinical activity; Cognitive impairment; Coping strategies; Multiple sclerosis; Relapses

Year:  2019        PMID: 31571134     DOI: 10.1007/s13760-019-01212-5

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  3 in total

1.  Some aspects of the natural history of disseminated sclerosis.

Authors:  D McALPINE; N COMPSTON
Journal:  Q J Med       Date:  1952-04

2.  Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis.

Authors:  David C Mohr; Donald E Goodkin; Sarah Nelson; Darcy Cox; Michael Weiner
Journal:  Psychosom Med       Date:  2002 Sep-Oct       Impact factor: 4.312

3.  Coping with multiple sclerosis: a 5-year follow-up study.

Authors:  K Lode; E Bru; G Klevan; K M Myhr; H Nyland; J P Larsen
Journal:  Acta Neurol Scand       Date:  2010-11       Impact factor: 3.209

  3 in total
  5 in total

1.  "I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study.

Authors:  Jonathan Koffman; Clarissa Penfold; Laura Cottrell; Bobbie Farsides; Catherine J Evans; Rachel Burman; Richard Nicholas; Stephen Ashford; Eli Silber
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

2.  Coping Strategies and Their Impact on Quality of Life and Physical Disability of People with Multiple Sclerosis.

Authors:  Silvia Cerea; Marta Ghisi; Marco Pitteri; Maddalena Guandalini; Lauren B Strober; Simona Scozzari; Francesco Crescenzo; Massimiliano Calabrese
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

Review 3.  Th17-cells in depression: Implication in multiple sclerosis.

Authors:  Mikhail Melnikov; Anna Lopatina
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

4.  Coping Strategies Furthering Post-Traumatic Growth in Multiple Sclerosis: A Longitudinal Study.

Authors:  Irene Gil-González; Agustín Martín-Rodríguez; Rupert Conrad; María Ángeles Pérez-San-Gregorio
Journal:  Int J Environ Res Public Health       Date:  2022-10-04       Impact factor: 4.614

5.  COVID-19 pandemic and mental distress in multiple sclerosis: Implications for clinical management.

Authors:  Teresa Costabile; Antonio Carotenuto; Luigi Lavorgna; Giovanna Borriello; Lucia Moiola; Matilde Inglese; Martina Petruzzo; Francesca Trojsi; Antonio Ianniello; Agostino Nozzolillo; Maria Cellerino; Giacomo Boffa; Laura Rosa; Giuseppe Servillo; Marcello Moccia; Simona Bonavita; Massimo Filippi; Roberta Lanzillo; Vincenzo Brescia Morra; Maria Petracca
Journal:  Eur J Neurol       Date:  2020-11-03       Impact factor: 6.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.